Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
Not recruiting
Investigated Diseases:
+4
Study of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
Not recruiting
Investigated Drugs:
+1
Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
Not recruiting
Investigated Drugs:
+5
Study on Etrasimod Arginine for Patients with Ulcerative Colitis, Alopecia Areata, Atopic Dermatitis, and Eosinophilic Esophagitis
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effectiveness and Safety of JNJ-95475939 and Dupilumab for Treating Moderate to Severe Atopic Dermatitis in Adults
Not recruiting
Investigated Drugs:
Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis
Not recruiting
Investigated Drugs:
